Carta Mauro Giovanni, Kalcev Goce, Scano Alessandra, Pinna Samantha, Gonzalez Cesar Ivan Aviles, Nardi Antonio Egidio, Orrù Germano, Primavera Diego
Department of Medical Sciences and Public Health, University of Cagliari, Monserrato Blocco I (CA), 09042 Cagliari, Italy.
Department of Surgical Sciences, University of Cagliari, Cittadella Universitaria, Blocco I, Asse Didattico Medicina P2, Monserrato (CA), 09042 Cagliari, Italy.
Clin Pract. 2023 Jul 27;13(4):853-862. doi: 10.3390/clinpract13040077.
Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 61, ≥60 years) received a clinical psychiatric evaluation, the MDQ, and were evaluated according to the presence of the genetic variant RS1006737 of CACNA1C. MDQ+ versus the diagnosis of BD as a gold standard shows a sensitivity of 0.286 (Cl 95% 0.14-0.39); a specificity of 0.925 (Cl 95% 0.85-0.08); a predictive positive value (PPV) of 0.667 (Cl 95% 0.33-0.91); and a predictive negative value (PNV) of 0.702 (Cl 95% 0.65-0.75). The positivity for the variant RS1006737 of the CACNA1C against the diagnosis of BD as a gold standard shows a sensitivity of 0.750 (Cl 95% 0.55-0.90); a specificity of 0.375 (Cl 95% 0.28-0.45); a PPV of 0.375 (Cl 95% 0.28-0.45); and a PNV of 0.750 (Cl 95% 0.55-0.90). The reliability between the MDQ+ and positivity for the variant RS1006737 of the CACNA1C was very low (K = -0.048, Cl 95% -0.20-0.09). The study found that both the genetic and the paper and pencil test were quite accurate, but were not reliable in case finding. In fact, despite some validity, albeit specular (in the case of a positive genetic test, the probability of having the disorder is very high, whereas in the case of a negative score on the paper and pencil test, the probability of not having the disorder is very high), the unreliability of the two tests (i.e., they certainly do not measure the same underlying dimension) opens the door to the need for an interpretation and the possibility of a synergistic use for screening. From a heuristic perspective, which obviously requires all of the necessary verifications, this study seems to suggest the hypothesis that a condition of hyperactivation common to disorders and stress conditions, and identified by a positive score on the MDQ (which is common to BD, post-traumatic stress disorder (PTSD), and anxiety disorders and whose genetic basis has not yet been clarified) can trigger BD in people with a predisposition to hyperactivity (i.e., in people with the condition identified by the analyzed genetic variant).
双相情感障碍(BD)是一个重要的公共卫生问题,因此准确的筛查工具可能会很有用。本研究的目的是验证作为筛查工具的心境障碍问卷(MDQ)和遗传风险的准确性,以及它们在可靠性方面的比较。老年人(N = 61,≥60岁)接受了临床精神科评估、MDQ,并根据CACNA1C基因变体RS1006737的存在情况进行评估。以BD诊断为金标准,MDQ阳性的灵敏度为0.286(95%置信区间0.14 - 0.39);特异度为0.925(95%置信区间0.85 - 0.08);阳性预测值(PPV)为0.667(95%置信区间0.33 - 0.91);阴性预测值(PNV)为0.702(95%置信区间0.65 - 0.75)。以BD诊断为金标准,CACNA1C基因变体RS1006737阳性的灵敏度为0.750(95%置信区间0.55 - 0.90);特异度为0.375(95%置信区间0.28 - 0.45);PPV为0.375(95%置信区间0.28 - 0.45);PNV为0.750(95%置信区间0.55 - 0.90)。MDQ阳性与CACNA1C基因变体RS1006737阳性之间的可靠性非常低(K = -0.048,95%置信区间 -0.20 - 0.09)。该研究发现,基因检测和纸笔测试都相当准确,但在病例发现方面并不可靠。事实上,尽管二者都有一定的效度,尽管是相反的(基因检测呈阳性时,患该疾病的概率非常高,而纸笔测试得分阴性时,不患该疾病的概率非常高),但这两种测试的不可靠性(即它们肯定没有测量相同的潜在维度)为解释的必要性以及协同用于筛查的可能性打开了大门。从启发式的角度来看,显然这需要所有必要的验证,本研究似乎提出了这样一个假设,即疾病和应激状态共有的一种过度激活状态,由MDQ阳性所识别(这在双相情感障碍、创伤后应激障碍(PTSD)和焦虑症中很常见,其遗传基础尚未阐明),可以在具有过度活跃倾向的人群中引发双相情感障碍(即具有所分析基因变体所识别的状态的人群)。